The lymphatic system: Integral roles in immunity

Annual Review of Immunology

Volumn 35, Issue , 2017, Pages 31-52

  Randolph, Gwendalyn J ^a   Ivanov, Stoyan ^a   Zinselmeyer, Bernd H ^a   Scallan, Joshua P ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adhesion; Endothelium; Lymph; Lymph node; Migration

Indexed keywords

PROTEIN;

BLOOD VESSEL PERMEABILITY; CAPILLARY; HUMAN; IMMUNE SYSTEM; IMMUNITY; INFLAMMATORY BOWEL DISEASE; INTERSTITIAL FLUID; LYMPH FLOW; LYMPH NODE; LYMPH VESSEL; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ANTIGEN PRESENTATION; ENDOTHELIUM CELL; IMMUNOLOGY; LIPID METABOLISM; LYMPHATIC SYSTEM; PHYSIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ENDOTHELIAL CELLS; HUMANS; IMMUNE SYSTEM; IMMUNITY; LIPID METABOLISM; LYMPHATIC SYSTEM; LYMPHATIC VESSELS;

EID: 85018361678     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-041015-055354     Document Type: Review

References (148)

1. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. 2012. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature 483:227-31
2. Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, et al. 2015. Quantifying Memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161:737-49
3. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effectormemory cells in nonlymphoid tissue. Science 291:2413-17
4. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101-5
5. Roozendaal R, Mebius RE. 2011. Stromal cell-immune cell interactions. Annu. Rev. Immunol. 29:23-43
6. Girard JP, Moussion C, Forster R. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12:762-73
7. Bronte V, Pittet MJ. 2013. The spleen in local and systemic regulation of immunity. Immunity 39:806-18
8. Randolph GJ, Miller NE. 2014. Lymphatic transport of high-density lipoproteins and chylomicrons. J. Clin. Investig. 124:929-35
9. Escolano A, Martinez-Martinez S, Alfranca A, Urso K, Izquierdo HM, et al. 2014. Specific calcineurin targeting inmacrophages confers resistance to inflammation viaMKP-1 and p38. EMBO J. 33:1117-33
10. Michel CC, Phillips ME. 1987. Steady-state fluid filtration at different capillary pressures in perfused frog mesenteric capillaries. J. Physiol. 388:421-35
11. Levick JR, Michel CC. 2010. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87:198-210
12. Michel CC, Nanjee MN, Olszewski WL, Miller NE. 2015. LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans. J. Lipid Res. 56:122-28
13. Stan RV, Tse D, Deharvengt SJ, Smits NC, Xu Y, et al. 2012. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev. Cell 23:1203-18
14. Mehta D, Malik AB. 2006. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86:279-367
15. Iijima N, Iwasaki A. 2016. Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help. Nature 533:552-56
16. Wiig H, Swartz MA. 2012. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol. Rev. 92:1005-60
17. Miller NE, Michel CC, Nanjee MN, Olszewski WL, Miller IP, et al. 2011. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. Am. J. Physiol. Endocrinol. Metab. 301:E659-67
18. Negrini D, Moriondo A. 2011. Lymphatic anatomy and biomechanics. J. Physiol. 589:2927-34
19. Chary SR, Jain RK. 1989. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. PNAS 86:5385-89
20. Boardman KC, Swartz MA. 2003. Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92:801-8
21. Randolph GJ, Angeli V, Swartz MA. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5:617-28
22. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. 2007. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11:526-38
23. Kolka CM, Castro AV, Kirkman EL, Bergman RN. 2015. Modest hyperglycemia prevents interstitial dispersion of insulin in skeletal muscle. Metabolism 64:330-37
24. Basu A, Dube S, Veettil S, Slama M, Kudva YC, et al. 2015. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J. Diabetes Sci. Technol. 9:63-68
25. Rossetti P, Bondia J, Vehi J, Fanelli CG. 2010. Estimating plasma glucose from interstitial glucose: the issue of calibration algorithms in commercial continuous glucosemonitoring devices. Sensors 10:10936-52
26. Chang CH, Qiu J, O'Sullivan D, Buck MD, Noguchi T, et al. 2015. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229-41
27. Swartz MA, Lund AW. 2012. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat. Rev. Cancer 12:210-19
28. Hagendoorn J, Padera TP, Kashiwagi S, Isaka N, Noda F, et al. 2004. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ. Res. 95:204-9
29. Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, et al. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab. 17:671-84
30. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, et al. 2007. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204:2349-62
31. Yao LC, Baluk P, Srinivasan RS, Oliver G, McDonald DM. 2012. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am. J. Pathol. 180:2561-75
32. Clement CC, Santambrogio L. 2013. The lymph self-antigen repertoire. Front. Immunol. 4:424
33. Lammermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Soldner R, et al. 2008. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453:51-55
34. Lammermann T, Sixt M. 2009. Mechanical modes of 'amoeboid' cell migration. Curr. Opin. Cell Biol. 21:636-44
35. Pflicke H, Sixt M. 2009. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206:2925-35
36. Overstreet MG, Gaylo A, Angermann BR, Hughson A, Hyun YM, et al. 2013. Inflammation-induced interstitial migration of effector CD4+ T cells is dependent on integrin aV. Nat. Immunol. 14:949-58
37. Ma J, Wang JH, Guo YJ, Sy MS, Bigby M. 1994. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol. 158:389-99
38. Xu H, Guan H, Zu G, Bullard D, Hanson J, et al. 2001. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 31:3085-93
39. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. 2006. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203:2763-77
40. Vassileva G, Soto H, Zlotnik A, Nakano H, Kakiuchi T, et al. 1999. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190:1183-88
41. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
42. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, et al. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-88
43. Randolph GJ, Bala S, Rahier JF, Johnson MW, Wang PL, et al. 2016. Lymphoid aggregates remodel lymphatic collecting vessels that serve mesenteric lymph nodes in Crohn disease. Am. J. Pathol. 186(12):3066-73
44. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, et al. 2005. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6:889-94
45. Vander Lugt B, Tubo NJ, Nizza ST, Boes M, Malissen B, et al. 2013. CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes. J. Immunol. 191:3119-27
46. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, et al. 2013. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339:328-32
47. Platt AM, Rutkowski JM, Martel C, Kuan EL, Ivanov S, et al. 2013. Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia. J. Immunol. 190:4608-20
48. Tomei AA, Siegert S, Britschgi MR, Luther SA, Swartz MA. 2009. Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J. Immunol. 183:4273-83
49. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, et al. 2001. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158:867-77
50. Locati M, Torre YM, Galliera E, Bonecchi R, Bodduluri H, et al. 2005. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev. 16:679-86
51. Weber M, Blair E, Simpson CV, O'Hara M, Blackburn PE, et al. 2004. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol. Biol. Cell 15:2492-508
52. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, et al. 2005. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur. J. Immunol. 35:1342-46
53. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, et al. 2010. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 59:197-206
54. Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, et al. 2011. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118:6220-29
55. Singh MD, King V, Baldwin H, Burden D, Thorrat A, et al. 2012. Elevated expression of the chemokinescavenging receptor D6 is associated with impaired lesion development in psoriasis. Am. J. Pathol. 181:1158-64
56. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, et al. 2007. Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6. PNAS 104:2319-24
57. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:19420-30
58. Jackson DG. 2009. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol. Rev. 230:216-31
59. Muto J, Morioka Y, Yamasaki K, Kim M, Garcia A, et al. 2014. Hyaluronan digestion controls DC migration from the skin. J. Clin. Investig. 124:1309-19
60. Jiang D, Liang J, Noble PW. 2007. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23:435-61
61. Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, et al. 2014. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Am. J. Respir. Crit. Care Med. 189:556-66
62. Kerjaschki D. 2006. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection? J. Nephrol. 19:403-6
63. Cui Y, Liu K, Monzon-Medina ME, Padera RF, Wang H, et al. 2015. Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection. J. Clin. Investig. 125:4255-68
64. Gale NW, Prevo R, Espinosa J, Ferguson DJ, Dominguez MG, et al. 2007. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol. Cell Biol. 27:595-604
65. Lynskey NN, Banerji S, Johnson LA, Holder KA, Reglinski M, et al. 2015. Rapid lymphatic dissemination of encapsulated group A streptococci via lymphatic vessel endothelial receptor-1 interaction. PLOS Pathog. 11:e1005137
66. Lawrance W, Banerji S, Day AJ, Bhattacharjee S, Jackson DG. 2016. Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization. J. Biol. Chem. 291:8014-30
67. Mummert ME, Mummert D, Edelbaum D, Hui F, Matsue H, Takashima A. 2002. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169:4322-31
68. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, et al. 2006. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+,CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J. Pathol. 209:67-77
69. Cho CH, Koh YJ, Han J, Sung HK, Jong Lee H, et al. 2007. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 100:e47-57
70. Pinto AR, Paolicelli R, Salimova E, Gospocic J, Slonimsky E, et al. 2012. An abundant tissuemacrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLOS ONE 7:e36814
71. Gautier EL, Ivanov S, Williams JW, Huang SC, Marcelin G, et al. 2014. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J. Exp. Med. 211:1525-31
72. Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, et al. 2008. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am. J. Pathol. 173:1202-9
73. Kuan EL, Ivanov S, Bridenbaugh EA, Victora G, Wang W, et al. 2015. Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node-homing adipose tissue dendritic cells. J. Immunol. 194:5200-10
74. Schmid-Schonbein GW. 1990. Microlymphatics and lymph flow. Physiol. Rev. 70:987-1028
75. Scallan JP, Wolpers JH, Muthuchamy M, Zawieja DC, Gashev AA, Davis MJ. 2012. Independent and interactive effects of preload and afterload on the pump function of the isolated lymphangion. Am. J. Physiol. Heart Circ. Physiol. 303:H809-24
76. Davis MJ, Scallan JP, Wolpers JH, Muthuchamy M, Gashev AA, Zawieja DC. 2012. Intrinsic increase in lymphangion muscle contractility in response to elevated afterload. Am. J. Physiol. Heart Circ. Physiol. 303:H795-808
77. Mathias R, von der Weid PY. 2013. Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis. Am. J. Physiol. Gastrointest. Liver Physiol. 304:G623-34
78. Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ. 2016. Lymphatic pumping: mechanics, mechanisms and malfunction. J. Physiol. 594:5749-68
79. Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S, et al. 2007. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21:2422-32
80. Ivanov S, Scallan JP, Kim KW, Werth K, Johnson MW, et al. 2016. CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability. J. Clin. Investig. 126:1581-91
81. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10:974-81
82. Mellor RH, Brice G, Stanton AW, French J, Smith A, et al. 2007. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 115:1912-20
83. Kazenwadel J, Betterman KL, Chong CE, Stokes PH, Lee YK, et al. 2015. GATA2 is required for lymphatic vessel valve development and maintenance. J. Clin. Investig. 125:2979-94
84. Danussi C, Del Bel Belluz L, Pivetta E, Modica TM, Muro A, et al. 2013. EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance. Mol. Cell Biol. 33:4381-94
85. Davis MJ, Rahbar E, Gashev AA, Zawieja DC, JE Moore Jr. 2011. Determinants of valve gating in collecting lymphatic vessels from rat mesentery. Am. J. Physiol. Heart Circ. Physiol. 301:H48-60
86. Scallan JP, Wolpers JH, Davis MJ. 2013. Constriction of isolated collecting lymphatic vessels in response to acute increases in downstream pressure. J. Physiol. 591:443-59
87. Nizamutdinova IT, Maejima D, Nagai T, Bridenbaugh E, Thangaswamy S, et al. 2014. Involvement of histamine in endothelium-dependent relaxation of mesenteric lymphatic vessels. Microcirculation 21:640-48
88. Kurtz KH, Moor AN, Souza-Smith FM, Breslin JW. 2014. Involvement of H1 and H2 receptors and soluble guanylate cyclase in histamine-induced relaxation of rat mesenteric collecting lymphatics. Microcirculation 21:593-605
89. Gashev AA, Davis MJ, Zawieja DC. 2002. Inhibition of the active lymph pump by flow in ratmesenteric lymphatics and thoracic duct. J. Physiol. 540:1023-37
90. Liao S, Cheng G, Conner DA, Huang Y, Kucherlapati RS, et al. 2011. Impaired lymphatic contraction associated with immunosuppression. PNAS 108:18784-89
91. Scallan JP, Davis MJ. 2013. Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels. J. Physiol. 591:2139-56
92. Bouta EM, Wood RW, Brown EB, Rahimi H, Ritchlin CT, Schwarz EM. 2014. In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice. J. Physiol. 592:1213-23
93. Brown MN, Fintushel SR, Lee MH, Jennrich S, Geherin SA, et al. 2010. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 185:4873-82
94. Geherin SA, Fintushel SR, Lee MH, Wilson RP, Patel RT, et al. 2012. The skin, a novel niche for recirculating B cells. J. Immunol. 188:6027-35
95. MacPherson GG, Jenkins CD, Stein MJ, Edwards C. 1995. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF dependence. J. Immunol. 154:1317-22
96. Ulvmar MH, Werth K, Braun A, Kelay P, Hub E, et al. 2014. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15:623-30
97. Qu C, Edwards EW, Tacke F, Angeli V, Llodra J, et al. 2004. Role of CCR8 and other chemokine pathways in themigration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200:1231-41
98. Das S, Sarrou E, Podgrabinska S, Cassella M, Mungamuri SK, et al. 2013. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J. Exp. Med. 210:1509-28
99. Rantakari P, Auvinen K, Jappinen N, Kapraali M, Valtonen J, et al. 2015. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nat. Immunol. 16:386-96
100. Pham TH, Baluk P, Xu Y, Grigorova I, Bankovich AJ, et al. 2010. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207:17-27
101. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, et al. 2006. CD69 acts downstream of interferonalpha/ beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:540-44
102. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, et al. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203-15
103. Tan KW, Yeo KP, Wong FH, Lim HY, Khoo KL, et al. 2012. Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation. J. Immunol. 188:4065-80
104. Tan KW, Chong SZ, Wong FH, Evrard M, Tan SM, et al. 2013. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. Blood 122:3666-77
105. Kataru RP, Kim H, Jang C, Choi DK, Koh BI, et al. 2011. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34:96-107
106. Cohen JN, Tewalt EF, Rouhani SJ, Buonomo EL, Bruce AN, et al. 2014. Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. PLOS ONE 9:e87740
107. Park SM, Angel CE, McIntosh JD, Mansell C, Chen CJ, et al. 2014. Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes. PLOS ONE 9:e94781
108. Cohen JN, Guidi CJ, Tewalt EF, Qiao H, Rouhani SJ, et al. 2010. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207:681-88
109. Chang JE, Turley SJ. 2015. Stromal infrastructure of the lymph node and coordination of immunity. Trends Immunol. 36:30-39
110. Hirosue S, Vokali E, Raghavan VR, Rincon-Restrepo M, Lund AW, et al. 2014. Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells. J. Immunol. 192:5002-11
111. Tamburini BA, Burchill MA, Kedl RM. 2014. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat. Commun. 5:3989
112. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, et al. 2012. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 13:499-510
113. Rouhani SJ, Eccles JD, Tewalt EF, Engelhard VH. 2014. Regulation of T-cell tolerance by lymphatic endothelial cells. J. Clin. Cell Immunol. 5:1000242
114. Dubrot J, Duraes FV, Potin L, Capotosti F, Brighouse D, et al. 2014. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance. J. Exp. Med. 211:1153-66
115. Kedl R, Finlon J, Tamburini B. 2016. Contraction of the hypertrophic lymph node and death of lymphatic endothelial cells as a process for antigen exchange. Presented at Lymphat. Gordon Res. Conf., Mar. 22, Ventura, CA
116. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, et al. 2012. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13:1118-28
117. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, et al. 2012. IL-7-producing stromal cells are critical for lymph node remodeling. Blood 120:4675-83
118. Miller CN, Hartigan-O'Connor DJ, Lee MS, Laidlaw G, Cornelissen IP, et al. 2013. IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia. Int. Immunol. 25:471-83
119. Hara T, Shitara S, Imai K, Miyachi H, Kitano S, et al. 2012. Identification of IL-7-producing cells in primary and secondary lymphoid organs using IL-7-GFP knock-in mice. J. Immunol. 189:1577-84
120. Shinoda K, Hirahara K, Iinuma T, Ichikawa T, Suzuki AS, et al. 2016. Thy1+IL-7+ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation. PNAS 113:E2842-51
121. Steinskog ES, Sagstad SJ, Wagner M, Karlsen TV, Yang N, et al. 2016. Impaired lymphatic function accelerates cancer growth. Oncotarget 7:45789-802
122. Adair TH, Moffatt DS, Paulsen AW, Guyton AC. 1982. Quantitation of changes in lymph protein concentration during lymph node transit. Am. J. Physiol. 243:H351-59
123. Hess PR, Rawnsley DR, Jakus Z, Yang Y, Sweet DT, et al. 2014. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J. Clin. Investig. 124:273-84
124. Bertozzi CC, Hess PR, Kahn ML. 2010. Platelets: covert regulators of lymphatic development. Arterioscler. Thromb. Vasc. Biol. 30:2368-71
125. Thomas SN, Rutkowski JM, Pasquier M, Kuan EL, Alitalo K, et al. 2012. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J. Immunol. 189:2181-90
126. Patel KM, Manrique O, Sosin M, Hashmi MA, Poysophon P, Henderson R. 2015. Lymphaticmapping and lymphedema surgery in the breast cancer patient. Gland Surg. 4:244-56
127. Warren S, Sommers SC. 1954. Pathology of regional ileitis and ulcerative colitis. J. Am. Med. Assoc. 154:189-93
128. de Souza HS, Fiocchi C. 2016. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13:13-27
129. Donia MS, Fischbach MA. 2015. Small molecules from the human microbiota. Science 349:1254766
130. Colombel JF, Watson AJ, Neurath MF. 2008. The 10 remaining mysteries of inflammatory bowel disease. Gut 57:429-33
131. Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH. 2014. Tertiary lymphoid structures in cancer and beyond. Trends Immunol. 35:571-80
132. Fonseca DM, Hand TW, Han SJ, Gerner MY, Glatman Zaretsky A, et al. 2015. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 163:354-66
133. Scallan JP, Huxley VH. 2010. In vivo determination of collecting lymphatic vessel permeability to albumin: a role for lymphatics in exchange. J. Physiol. 588:243-54
134. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, et al. 2011. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells. J. Exp. Med. 208:125-34
135. Aldrich MB, Sevick-Muraca EM. 2013. Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine 64:362-69
136. Vitavska O, Edemir B, Wieczorek H. 2016. Putative role of the H+/sucrose symporter SLC45A3 as an osmolyte transporter in the kidney. Pflugers Arch. 468:1353-62
137. Hofmeister LH, Perisic S, Titze J. 2015. Tissue sodium storage: evidence for kidney-like extrarenal countercurrent systems? Pflugers Arch. 467:551-58
138. Boukens BJ, Christoffels VM. 2012. Popeye proteins: muscle for the aging sinus node. J. Clin. Investig. 122:810-13
139. Yang Y, Oliver G. 2014. Transcriptional control of lymphatic endothelial cell type specification. Adv. Anat. Embryol. Cell Biol. 214:5-22
140. Jackson DG. 2003. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc. Med. 13:1-7
141. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, et al. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154:385-94
142. Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, et al. 2010. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115:3997-4005
143. Platt N, Gordon S. 2001. Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale. J. Clin. Investig. 108:649-54
144. Harris EN, Weigel JA, Weigel PH. 2008. The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J. Biol. Chem. 283:17341-50
145. Jurisic G, Maby-El Hajjami H, Karaman S, Ochsenbein AM, Alitalo A, et al. 2012. An unexpected role of semaphorin3A-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ. Res. 111:426-36
146. Copeland SJ, Thurston SF, Copeland JW. 2016. Actin-andmicrotubule-dependent regulation ofGolgi morphology by FHDC1. Mol. Biol. Cell 27:260-76
147. Moore TC. 1984. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology 52:511-18
148. Formoso K, Garcia MD, Frasch AC, Scorticati C. 2015. Filopodia formation driven by membrane glycoprotein M6a depends on the interaction of its transmembrane domains. J. Neurochem. 134:499-512